EUVIMEDEUVIMED entdecken
Crossref

De novo-designed pMHC binders facilitate T cell–mediated cytotoxicity toward cancer cells

Kristoffer Haurum Johansen iD, Darian Stephan Wolff iD, Beatrice Scapolo iD, Monica L Fernández-Quintero iD, Charlotte Risager Christensen iD, Johannes R Loeffler iD, Esperanza Rivera-de-Torre iD, Max D Overath iD, Kamilla Kjærgaard Munk iD, Oliver Morell iD, Marie Christine Viuff iD, Iñigo Lacunza iD und 15 weitere

Science · 24.07.2025 · 389 (6758) · 380-385

DOI: 10.1126/science.adv0422 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science, erschienen am 24.07.2025. Verfasst von Kristoffer Haurum Johansen und 26 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Technology, Technical University of Denmark, Kongens Lyngby, Denmark. Hauptthemen laut MEDLINE: Antigens, Neoplasm, CD8-Positive T-Lymphocytes, Cytotoxicity, Immunologic, HLA-A2 Antigen. Die Arbeit wurde bisher 80-mal zitiert (Crossref) und nennt 50 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The recognition of intracellular antigens by CD8 + T cells through T cell receptors (TCRs) is central for adaptive immunity against infections and cancer. However, the identification of TCRs from patient material remains complex. We present a rapid de novo minibinder (miBd) design platform leveraging state-of-the-art generative models to engineer miBds targeting the cancer-associated peptide-bound major histocompatibility complex (pMHC) SLLMWITQC/HLA-A*02:01 (NY-ESO-1). Incorporating in silico cross-panning enabled computational prescreening of specificity, and molecular dynamics simulations allowed for improved predictability of in vitro success. We identified a high-affinity NY-ESO-1 binder and confirmed its structure using cryo–electron microscopy, which, when incorporated in a chimeric antigen receptor, induced killing of NY-ESO-1 + melanoma cells. We further designed and validated binders to a neoantigen pMHC complex, RVTDESILSY/HLA-A*01:01, with unknown structure, demonstrating the potential for precision immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antigens, NeoplasmCD8-Positive T-LymphocytesCytotoxicity, ImmunologicHLA-A2 AntigenMajor Histocompatibility ComplexMelanomaMembrane ProteinsReceptors, Antigen, T-CellMolecular MimicryHumansCell Line, TumorCryoelectron MicroscopyMolecular Dynamics SimulationPeptidesProtein BindingProtein EngineeringReceptors, Chimeric AntigenProtein Conformation, alpha-Helical

Substanzen

Antigens, NeoplasmCTAG1B protein, humanHLA-A*02:01 antigenHLA-A2 AntigenMembrane ProteinsPeptidesReceptors, Antigen, T-CellReceptors, Chimeric Antigen

Autor:innen und Institutionen

  • Department of Health Technology, Technical University of Denmark, Kongens Lyngby, Denmark.
  • Department of Biotechnology and Biomedicine, Technical University of Denmark, Kongens Lyngby, Denmark.
  • Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA.

ORCID-Profile: Kristoffer Haurum Johansen, Darian Stephan Wolff, Beatrice Scapolo, Monica L Fernández-Quintero, Charlotte Risager Christensen, Johannes R Loeffler, Esperanza Rivera-de-Torre, Max D Overath, Kamilla Kjærgaard Munk, Oliver Morell, Marie Christine Viuff, Iñigo Lacunza, Alberte T Damm Englund, Mathilde Due, Anant Gharpure, Stefano Forli, Carlos Rodriguez Pardo, Tripti Tamhane, Kasper Haldrup Björnsson, Jordan Sylvester Fernandes, Lasse Frank Voss, Suthimon Thumtecho, Andrew B Ward, Maria Ormhøj, Sine Reker Hadrup, Timothy P Jenkins

Zitieren

APA

Johansen, K. H., Wolff, D. S., Scapolo, B., Fernández-Quintero, M. L., Risager Christensen, C., Loeffler, J. R., Rivera-de-Torre, E., Overath, M. D., Kjærgaard Munk, K., Morell, O., Viuff, M. C., Lacunza, I., Damm Englund, A. T., Due, M., Gharpure, A., Forli, S., Rodriguez Pardo, C., Tamhane, T., Qingjie Andersen, E., …, & Jenkins, T. P. (2025). De novo-designed pMHC binders facilitate T cell–mediated cytotoxicity toward cancer cells. Science, 389(6758), 380-385. https://doi.org/10.1126/science.adv0422

Vancouver

Johansen KH, Wolff DS, Scapolo B, Fernández-Quintero ML, Risager Christensen C, Loeffler JR, et al. De novo-designed pMHC binders facilitate T cell–mediated cytotoxicity toward cancer cells. Science. 2025;389(6758):380-385. doi:10.1126/science.adv0422

BibTeX
@article{Johansen2025,
  author = {Johansen, Kristoffer Haurum and Wolff, Darian Stephan and Scapolo, Beatrice and Fernández-Quintero, Monica L and Risager Christensen, Charlotte and Loeffler, Johannes R and Rivera-de-Torre, Esperanza and Overath, Max D and Kjærgaard Munk, Kamilla and Morell, Oliver and Viuff, Marie Christine and Lacunza, Iñigo and Damm Englund, Alberte T and Due, Mathilde and Gharpure, Anant and Forli, Stefano and Rodriguez Pardo, Carlos and Tamhane, Tripti and Qingjie Andersen, Emma and Haldrup Björnsson, Kasper and Fernandes, Jordan Sylvester and Voss, Lasse Frank and Thumtecho, Suthimon and Ward, Andrew B and Ormhøj, Maria and Reker Hadrup, Sine and Jenkins, Timothy P},
  title = {De novo-designed pMHC binders facilitate T cell–mediated cytotoxicity toward cancer cells},
  journal = {Science},
  year = {2025},
  volume = {389},
  number = {6758},
  pages = {380--385},
  doi = {10.1126/science.adv0422}
}
Kostenlos starten →